EUVIMEDEUVIMED entdecken
Open Access

SARM1, an Enzyme Involved in Axon Degeneration, Catalyzes Multiple Activities through a Ternary Complex Mechanism

Janneke D Icso, Leonard Barasa, Paul R Thompson iD

Biochemistry · 04.07.2023 · 62 (13) · 2065-2078

DOI: 10.1021/acs.biochem.3c00081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry, online erschienen am 12.06.2023. Verfasst von Janneke D Icso und 2 weiteren Autor:innen. Beteiligte Einrichtung: Program in Chemical Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01605, United States. Hauptthemen laut MEDLINE: Axons, NAD. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sterile alpha and toll/interleukin receptor (TIR) motif containing protein 1 (SARM1) is an NAD+ hydrolase and cyclase involved in axonal degeneration. In addition to NAD+ hydrolysis and cyclization, SARM1 catalyzes a base exchange reaction between nicotinic acid (NA) and NADP+ to generate NAADP, which is a potent calcium signaling molecule. Herein, we describe efforts to characterize the hydrolysis, cyclization, and base exchange activities of TIR-1, the Caenorhabditis elegans ortholog of SARM1; TIR-1 also catalyzes NAD(P)+ hydrolysis and/or cyclization and regulates axonal degeneration in worms. We show that the catalytic domain of TIR-1 undergoes a liquid-to-solid phase transition that regulates not only the hydrolysis and cyclization reactions but also the base exchange reaction. We define the substrate specificities of the reactions, demonstrate that cyclization and base exchange reactions occur within the same pH range, and establish that TIR-1 uses a ternary complex mechanism. Overall, our findings will aid drug discovery efforts and provide insight into the mechanism of recently described inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AxonsNADAnimalsCatalytic DomainCaenorhabditis elegans

Substanzen

NAD

Autor:innen und Institutionen

  • Program in Chemical Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01605, United States.
  • Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medial School, Worcester, Massachusetts 01605, United States.

ORCID-Profile: Paul R Thompson

Förderung

  • NINDS NIH HHS
  • NIGMS NIH HHS
  • NIAID NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • National Institute of Allergy and Infectious Diseases
  • National Institute of General Medical Sciences
  • Dan and Dianne Riccio Fund for Neuroscience

Zitieren

APA

Icso, J. D., Barasa, L., & Thompson, P. R. (2023). SARM1, an Enzyme Involved in Axon Degeneration, Catalyzes Multiple Activities through a Ternary Complex Mechanism. Biochemistry, 62(13), 2065-2078. https://doi.org/10.1021/acs.biochem.3c00081

Vancouver

Icso JD, Barasa L, Thompson PR. SARM1, an Enzyme Involved in Axon Degeneration, Catalyzes Multiple Activities through a Ternary Complex Mechanism. Biochemistry. 2023;62(13):2065-2078. doi:10.1021/acs.biochem.3c00081

BibTeX
@article{Icso2023,
  author = {Icso, Janneke D and Barasa, Leonard and Thompson, Paul R},
  title = {SARM1, an Enzyme Involved in Axon Degeneration, Catalyzes Multiple Activities through a Ternary Complex Mechanism},
  journal = {Biochemistry},
  year = {2023},
  volume = {62},
  number = {13},
  pages = {2065--2078},
  doi = {10.1021/acs.biochem.3c00081}
}
Kostenlos starten →